Delivery Order SPE2DB24D8002-SPE2DB24FJMWX
Award Date
9/6/24
Potential Completion Date
9/9/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2UG7, was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to the prime contractor Dakota Drug, Inc. The $6,308.13 firm fixed-price delivery order is for the provision of ORENCIA 125 MG/ML SYRINGEML, a pharmaceutical product, to support medical supply chain operations. Dakota Drug, Inc. is a self-certified small disadvantaged business that specializes in supplying pharmaceutical...
This federal contract award, identified as SPE2DB24D8002|SPE2DB24FJMQJ, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,662.00 Firm Fixed Price Delivery Order is for the pharmaceutical product ORENCIA 125 MG/ML SYRINGEML. The award is not associated with a set-aside program and has an ultimate completion date of July 23, 2024. Dakota Drug, Inc. has an existing Indefinite Delivery Contract (IDC) with the DLA, contract...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYUQ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $10,348.93, is for the delivery of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. This contract is part of the DLA Troop Support Medical's ECAT Generation V Program, an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order valued at $5,032.29 for the delivery of ORENCIA CLICKJECT 125 MG/MLML, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance extending to November 17, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The award, valued at $10,206.57, is for the delivery of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products. This contract has a performance period extending through September 20, 2023 and is a firm fixed-price delivery order with no set-aside designation. Dakota Drug, Inc. holds a significant single-award Indefinite...
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2UQ0, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Orencia 125 mg/ml syringes. The contract is a firm-fixed-price Delivery Order with a ceiling value of $10,460.93 and a completion date of January 23, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a $999,999,999.00 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $5,132.04, is for the provision of Orencia ClickJect 125 mg/ml, a pharmaceutical product. The award is not designated as a set-aside contract. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ORENCIA 125 MG/ML SYRINGE/ML pharmaceutical products, with a ceiling value of $5,274.04 and a period of performance through December 5, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of Defense, holding a significant single-award Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,224.96 contract is for the delivery of ORENCIA 125 MG/ML SYRINGE/ML, a biologic drug used to treat autoimmune conditions. The contract has an ultimate completion date of May 13, 2024 and was awarded on May 10, 2024 without a set-aside designation. Dakota Drug,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to the small disadvantaged business Dakota Drug, Inc. for the procurement of ORENCIA CLICKJECT 125 MG/MLML. The contract has a firm fixed price of $11,464.47 and a performance period through January 26, 2024. Dakota Drug, Inc. is a key supplier for the DLA's medical supply chain, holding a $999,999,999.00 Indefinite Delivery Contract under the ECAT Generation V Program to provide a wide...